IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

RANDON, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.006
NA - Nord America 2.581
AS - Asia 2.484
SA - Sud America 262
Continente sconosciuto - Info sul continente non disponibili 218
AF - Africa 56
OC - Oceania 19
Totale 8.626
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.449
DE - Germania 1.390
CN - Cina 781
SG - Singapore 630
IT - Italia 557
BD - Bangladesh 327
GB - Regno Unito 217
BR - Brasile 198
SE - Svezia 192
VN - Vietnam 154
HK - Hong Kong 148
IN - India 135
FR - Francia 131
RU - Federazione Russa 124
JP - Giappone 106
CA - Canada 96
NL - Olanda 68
ES - Italia 56
FI - Finlandia 54
TR - Turchia 51
IE - Irlanda 49
DK - Danimarca 36
ID - Indonesia 29
CI - Costa d'Avorio 28
PL - Polonia 27
AR - Argentina 22
BE - Belgio 17
UA - Ucraina 17
AU - Australia 15
CH - Svizzera 15
MX - Messico 15
KR - Corea 14
TW - Taiwan 13
IQ - Iraq 12
PK - Pakistan 11
UZ - Uzbekistan 11
AT - Austria 10
PH - Filippine 10
CL - Cile 9
EC - Ecuador 9
ZA - Sudafrica 9
CO - Colombia 8
SA - Arabia Saudita 8
GR - Grecia 6
MA - Marocco 6
PT - Portogallo 6
AE - Emirati Arabi Uniti 5
IR - Iran 5
MY - Malesia 5
RS - Serbia 5
VE - Venezuela 5
AL - Albania 4
CZ - Repubblica Ceca 4
EG - Egitto 4
HU - Ungheria 4
JM - Giamaica 4
JO - Giordania 4
RO - Romania 4
TH - Thailandia 4
AP - ???statistics.table.value.countryCode.AP??? 3
BO - Bolivia 3
CR - Costa Rica 3
DZ - Algeria 3
HN - Honduras 3
MO - Macao, regione amministrativa speciale della Cina 3
NZ - Nuova Zelanda 3
PE - Perù 3
SI - Slovenia 3
UY - Uruguay 3
BB - Barbados 2
BH - Bahrain 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
NO - Norvegia 2
NP - Nepal 2
PS - Palestinian Territory 2
PY - Paraguay 2
AS - Samoa Americane 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BW - Botswana 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GL - Groenlandia 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
KW - Kuwait 1
LC - Santa Lucia 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
PR - Porto Rico 1
Totale 8.404
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 1.291
Singapore 384
Ashburn 375
Chandler 222
Southend 146
San Jose 134
Milan 124
Hong Kong 119
Beijing 108
Los Angeles 98
Santa Clara 84
Council Bluffs 77
New York 76
Dallas 74
Fairfield 58
Shanghai 56
Wilmington 50
Dublin 49
Ho Chi Minh City 48
Redwood City 48
Princeton 47
Helsinki 43
Boardman 40
Bengaluru 39
Hanoi 39
Ann Arbor 38
Dearborn 38
Toronto 38
Houston 37
Rome 34
Guangzhou 33
Cambridge 32
Tokyo 31
Munich 30
Woodbridge 30
Lauterbourg 29
Abidjan 28
Buffalo 28
Istanbul 27
Seattle 26
Chicago 25
Nanjing 24
Shenyang 23
Changsha 22
Des Moines 22
Jakarta 22
Moscow 22
Naples 21
São Paulo 20
Tianjin 20
Hangzhou 19
Phoenix 19
Montreal 17
Columbus 16
Fuzhou 16
Pune 16
Atlanta 14
Brussels 14
Grafing 14
London 14
Paris 14
Turin 14
Wuhan 14
Amsterdam 13
Jinan 13
Mumbai 13
The Dalles 13
Bari 12
Central District 12
Genoa 12
San Francisco 12
Cangzhou 11
Hefei 11
Hyderabad 11
Turku 11
Nanchang 10
Bologna 9
Seoul 9
Warsaw 9
Chengdu 8
Rio de Janeiro 8
San Diego 8
Fremont 7
Johannesburg 7
New Delhi 7
Ningbo 7
Nuremberg 7
Palermo 7
Philadelphia 7
Shenzhen 7
Stockholm 7
Taipei 7
Zhengzhou 7
Bergamo 6
Da Nang 6
Falls Church 6
Haiphong 6
Lille 6
Orem 6
Taizhou 6
Totale 5.054
Salva come PNG Salva come JPEG
Nome #
Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer 885
Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET) 552
Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer 456
The added value of baseline circulating tumor DNA profiling in patients with molecularly hyperselected, left-sided metastatic colorectal cancer 427
Prognostic impact of ATM mutations in patients with metastatic colorectal cancer 383
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients with Potentially Resectable Colorectal Cancer Liver Metastases 340
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak : COVID-19-adapted Recommendations of the National Cancer Institute of Milan 317
Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD-L1 in Gastric Cancer Patients Treated with Either Adjuvant 5-FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel : A Translational Analysis from the ITACA-S Trial. Oncologist 307
Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma Peritonei 301
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden 294
The landscape of actionable gene fusions in colorectal cancer 286
Validation of the Colon Life nomogram in patients with refractory metastatic colorectal cancer enrolled in the RECOURSE trial 269
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers 268
Biomarker-guided implementation of the old drug temozolomide as a novel treatment option for patients with metastatic colorectal cancer 259
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series 255
Combination of baseline LDH, performance status and age as integrated algorithm to identify solid tumor patients with higher probability of response to anti PD-1 and PD-l1 monoclonal antibodies 244
Atypical RAS Mutations in Metastatic Colorectal Cancer 244
Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake 234
Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer 231
Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylation 215
KRAS G12C Metastatic Colorectal Cancer : Specific Features of a New Emerging Target Population 209
Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study 208
The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy 194
MGMT Promoter Methylation as a Target In Metastatic Colorectal Cancer : Rapid Turnover and Use of Folates Alter its Study-Response 193
“Systemic strategy at the patient’s service”: A congress report on supportive care in oncology 177
Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study 165
Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma 151
The Italian instrument evaluating the nursing students clinical learning quality 139
Pembrolizumab in the treatment of advanced/metastatic melanoma: a single-center institution experience 132
Management of patients with locally recurrent rectal cancer with a previous history of distant metastases: retrospective cohort study 132
Nursing students’ experience of the mental health setting as a clinical learning environment: Findings from a national study 124
Re-treatment with panitumumab followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA: the PARERE study by GONO 32
null 3
Totale 8.626
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.786
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.786
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022555 0 0 46 41 32 41 34 46 72 83 24 136
2022/2023714 72 102 81 71 57 120 21 60 52 13 46 19
2023/20241.323 26 36 46 49 86 42 221 167 84 158 202 206
2024/20251.691 184 213 156 197 101 90 102 115 58 118 143 214
2025/20262.598 254 144 233 147 229 128 334 73 196 167 397 296
2026/2027588 216 361 11 0 0 0 0 0 0 0 0 0
Totale 8.626